Review: taking Enalapril maleate and Furosemide together


Summary

Drug interactions are reported among people who take Enalapril maleate and Furosemide together. This review analyzes the effectiveness and drug interactions between Enalapril maleate and Furosemide. It is created by eHealthMe based on reports of 11,175 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Enalapril Maleate

Enalapril maleate has active ingredients of enalapril maleate. It is often used in high blood pressure. (latest outcomes from Enalapril maleate 26,766 users)

Furosemide

Furosemide has active ingredients of furosemide. It is often used in high blood pressure. (latest outcomes from Furosemide 121,372 users)

On Sep, 17, 2016

11,175 people who take Enalapril Maleate, Furosemide are studied.


Number of reports submitted per year:

Enalapril maleate and Furosemide drug interactions.

Drug effectiveness over time:

Enalapril Maleate:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 50.0% - (2 of 4 people)
  • 6 - 12 months: 25.0% - (1 of 4 people)
  • 1 - 2 years: 75.0% - (3 of 4 people)
  • 2 - 5 years: 37.0% - (3 of 8 people)
  • 5 - 10 years: 40.0% - (2 of 5 people)
  • 10+ years: 66.0% - (4 of 6 people)
  • not specified: 0.0% - (0 of 0 people)
Furosemide:
  • < 1 month: 50.0% - (2 of 4 people)
  • 1 - 6 months: 0.0% - (0 of 3 people)
  • 6 - 12 months: 40.0% - (2 of 5 people)
  • 1 - 2 years: 50.0% - (2 of 4 people)
  • 2 - 5 years: 50.0% - (3 of 6 people)
  • 5 - 10 years: 85.0% - (6 of 7 people)
  • 10+ years: 50.0% - (2 of 4 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Enalapril Maleate:
  • female: 40.0% - (6 of 15 people)
  • male: 52.0% - (10 of 19 people)
Furosemide:
  • female: 53.0% - (7 of 13 people)
  • male: 50.0% - (10 of 20 people)

Drug effectiveness by age:

Enalapril Maleate:
  • 0-1: 66.0% - (2 of 3 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 62.0% - (5 of 8 people)
  • 50-59: 25.0% - (1 of 4 people)
  • 60+: 50.0% - (8 of 16 people)
Furosemide:
  • 0-1: 66.0% - (2 of 3 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 71.0% - (5 of 7 people)
  • 50-59: 50.0% - (2 of 4 people)
  • 60+: 50.0% - (8 of 16 people)

Most common drug interactions over time *:

< 1 month:
  • dehydration
  • renal failure acute
  • blood creatinine increased
  • renal impairment
  • hypotension
  • decreased appetite
  • cardiac failure
  • abdominal pain
  • blood urea increased
  • hyperkalaemia
1 - 6 months:
  • cardiac failure
  • concomitant disease progression
  • hyperkalaemia
  • dyspnoea
  • renal impairment
  • disease progression
  • blood creatinine increased
  • atrial fibrillation
  • hypotension
  • renal failure acute
6 - 12 months:
  • renal failure acute
  • hyperkalaemia
  • cardiac failure
  • anaemia
  • dehydration
  • death
  • hyponatraemia
  • oedema peripheral
  • general physical health deterioration
  • renal impairment
1 - 2 years:
  • renal failure acute
  • syncope
  • hyperkalaemia
  • cardiac failure
  • atrial fibrillation
  • cardiac failure congestive
  • renal impairment
  • concomitant disease progression
  • disease progression
  • dyspnoea
2 - 5 years:
  • cardiac failure
  • renal failure acute
  • hyperkalaemia
  • dehydration
  • dyspnoea
  • hypotension
  • cardiac failure acute
  • renal impairment
  • cardiac failure congestive
  • syncope
5 - 10 years:
  • hyperkalaemia
  • renal failure acute
  • renal failure
  • dehydration
  • pruritus
  • asthenia
  • hypoglycaemia
  • blood creatinine increased
  • cardiac failure
  • cardiac failure congestive
10+ years:
  • nephrotic syndrome
  • angioedema
  • gastrointestinal haemorrhage
  • renal failure
  • renal impairment
  • cardiac failure
  • cardiorenal syndrome
  • polyuria
  • pruritus generalised
  • acute myocardial infarction
not specified:
  • cardiac failure congestive
  • dyspnoea
  • pain
  • renal failure acute
  • nausea
  • fatigue
  • hypotension
  • anaemia
  • asthenia
  • oedema peripheral

Most common drug interactions by gender *:

female:
  • cardiac failure congestive
  • pain
  • dyspnoea
  • nausea
  • fatigue
  • renal failure acute
  • anaemia
  • hypotension
  • pleural effusion
  • vomiting
male:
  • dyspnoea
  • cardiac failure congestive
  • renal failure acute
  • hypotension
  • cardiac failure
  • blood creatinine increased
  • nausea
  • hyperkalaemia
  • pain
  • asthenia

Most common drug interactions by age *:

0-1:
  • renal failure acute
  • hypotension
  • pyrexia
  • blood creatinine increased
  • blood urea increased
  • dehydration
  • hyperkalaemia
  • proteinuria
  • hyponatraemia
  • respiratory failure
2-9:
  • blood pressure decreased
  • cardiac failure congestive
  • pyrexia
  • renal impairment
  • pain
  • anxiety
  • diarrhoea
  • dyspnoea
  • platelet count decreased
  • renal failure acute
10-19:
  • vomiting
  • renal failure
  • headache
  • nausea
  • cardiac failure
  • hypotension
  • oedema peripheral
  • pain
  • alanine aminotransferase increased
  • convulsion
20-29:
  • vomiting
  • bronchitis
  • nausea
  • cardiac failure congestive
  • stevens-johnson syndrome
  • cardiac failure
  • diarrhoea
  • multi-organ failure
  • renal failure
  • sinusitis
30-39:
  • cardiac failure congestive
  • pyrexia
  • convulsion
  • nausea
  • cardiac failure
  • chest pain
  • dyspnoea
  • hypertension
  • oedema peripheral
  • anaemia
40-49:
  • cardiac failure congestive
  • weight increased
  • pain
  • dyspnoea
  • chest pain
  • anxiety
  • myocardial infarction
  • renal failure acute
  • hypotension
  • hypertension
50-59:
  • cardiac failure congestive
  • dyspnoea
  • pain
  • nausea
  • chest pain
  • anxiety
  • oedema peripheral
  • renal failure acute
  • emotional distress
  • fall
60+:
  • cardiac failure congestive
  • renal failure acute
  • dyspnoea
  • fatigue
  • nausea
  • pain
  • hypotension
  • anaemia
  • asthenia
  • hyperkalaemia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Enalapril maleate and Furosemide?

Can you answer these questions?

More questions for: Enalapril maleate, Furosemide

You may be interested in these reviews

More reviews for: Enalapril maleate, Furosemide

On eHealthMe, Enalapril maleate (enalapril maleate) is often used to treat high blood pressure. Furosemide (furosemide) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.